Hydroxychloroquine (Plaquenil) 300 mg Daily is Safe for Pregnancy Planning
Yes, continuing hydroxychloroquine 300 mg daily (1.5 tablets of 200 mg) is safe and strongly recommended if you are planning to become pregnant with rheumatoid arthritis. 1, 2
Guideline-Based Recommendation
The American College of Rheumatology strongly recommends continuing hydroxychloroquine during pregnancy if already taking it, and conditionally recommends starting it if not already prescribed (unless contraindicated by allergy or intolerance). 1
The EULAR guidelines explicitly list hydroxychloroquine as a pregnancy-compatible antirheumatic drug that should be continued for maintenance of remission or treatment of disease flares. 1
Do not discontinue hydroxychloroquine when planning pregnancy or after becoming pregnant, as stopping the medication can precipitate disease flares and increase maternal morbidity without providing any fetal benefit. 1, 2
Your Specific Dose is Safe
Your prescribed dose of 300 mg daily (1.5 × 200 mg tablets) falls well within the safe range for pregnancy. 1
The FDA label indicates typical doses of 200-400 mg daily for rheumatoid arthritis, and your dose is in the middle of this range. 3
The maximum safe dose is 400 mg daily or 6.5 mg/kg per day, whichever is lower. 3 At your weight of 107 lb (approximately 49 kg), your maximum safe dose would be 318 mg daily, so your 300 mg dose is appropriate. 3
Safety Evidence for Pregnancy
A 2025 Swedish population-based cohort study of 1,007 births in women with lupus or RA found no significantly increased risk of major congenital malformations with first-trimester hydroxychloroquine exposure (adjusted risk ratio 1.30,95% CI 0.76-2.23). 4
A 2022 prospective cohort study of 279 pregnant women exposed to hydroxychloroquine found major birth defects occurred in 8.6% of exposed women versus 7.4% of disease-matched unexposed controls (not statistically different), with no pattern of birth defects identified. 5
A 2003 study of 133 pregnancies in women treated with hydroxychloroquine (mostly 400 mg daily) found 88% ended successfully with live births, with no statistical difference in pregnancy outcomes compared to controls. 6
Benefits of Continuing Hydroxychloroquine
Active rheumatoid arthritis during pregnancy increases the risk of adverse pregnancy outcomes including preterm delivery, low birth weight, spontaneous abortion, fetal death, preeclampsia, and intrauterine growth restriction. 1
Hydroxychloroquine reduces disease flares during pregnancy, and cessation is associated with significantly increased disease activity and flare rates. 1
Optimal disease control should be achieved before conception to minimize pregnancy risks. 2, 7
Additional Recommendations for Pregnancy Planning
Add folic acid supplementation (at least 400-800 mcg daily, or 5 mg daily if also taking sulfasalazine) before conception and throughout pregnancy. 7
Continue hydroxychloroquine throughout all three trimesters of pregnancy. 1, 2
Monitor disease activity at least once per trimester during pregnancy. 7
Hydroxychloroquine is also compatible with breastfeeding, as it has limited transfer into breast milk. 1, 2
Critical Contraindications to Check
Known allergy to hydroxychloroquine or chloroquine is an absolute contraindication. 1
G6PD deficiency is a relative contraindication due to hemolysis risk, though recent data suggest lower risk than previously thought. 1
If you have neither of these conditions, there are no contraindications to continuing hydroxychloroquine during pregnancy planning and pregnancy. 1
Common Pitfall to Avoid
The most common and harmful mistake is discontinuing hydroxychloroquine when planning pregnancy or after becoming pregnant. 1, 2 This can precipitate disease flares that harm both mother and fetus, and disease flares can be prevented by continuing this pregnancy-compatible medication. 2